Filter posts

102 Organizations Urge Congress to Maintain a Strong Patent System and Protect Innovation

A diverse group of more than 100 national and state-based advocacy organizations have united to …

CNBC Commentary: Hedge funds, 'reverse trolls' crushing biopharma innovation

Patents are the lifeblood of medical innovation. They are the cornerstone that enables companies to …

2015 BIO World Congress Will Hold Workshops Focusing on Current Investment Trends

BIO recently announced the schedule of workshops for the 2015 World Congress on Industrial Biotechnology. These workshops …

IP Sessions at BIO 2015: The Impact of the Inter Partes Review on (BIO)Pharma

The Intellectual Property Track at the BIO International Convention was a chance for IP thought …

Sen Menendez Asks SEC to Investigate IPR Abuses

New Jersey Senator Bob Menendez has asked the Securities and Exchange Commissioner (SEC) to investigate …

11 Days Until BIO 2015: IP Networking and Meetup Opportunities

This year’s BIO International Convention is fast approaching, with plenty of opportunities for the best …

BIO Deputy General Counsel Testifies on Patent Reform

On Wednesday, March 18, BIO’s Deputy Counsel for Intellectual Property, Hans Sauer, testified in front …

When The Deck is Stacked Against Innovators, Everyone Loses

Yesterday, I took part in a series of successful meetings on Capitol Hill regarding the …

Should the USPTO Allow the Patenting of Living Organisms?

Last year, a question was submitted to the GMO advocacy website GMOAnswers about whether or …

The Washington Post: Are Patents the Problem?

Tamar Haspel, food columnist for the Washington Post, looks at the issue of seed patents …